Samsung Changwon Medical Center — Changwon, Gyeongsangnam-do

Public research footprint of Samsung Changwon Medical Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Cardiac Event · Breast Cancer Classified as TNM Stage 0-IIIa · Gastric or Gastroesophageal Junction Adenocarcinoma · Germline BRCA1 Gene Mutation

Recently updated registry entries

NCT07741721 — Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (Not Yet Recruiting)
NCT07577518 — Comparison of the Incidence of Major Cardiovascular Events Between the Combination of… (Not Yet Recruiting)
NCT06333964 — A Study to Evaluate the Efficacy and Safety of AST-001 in ASD Children (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Samsung Changwon Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.